{ "items": [ "\n\n
\n \n 3 April 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nBrainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted \u00a37m ($9.8m) of investment to bring its software to the global healthcare market. The company was spun out from Oxford University research.
\n \n\n\n \n 13 March 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe march towards replacing animals in drug testing with computer simulations has made another significant step forward, with the development of new software which can predict the possible cardiac side effects of taking a new drug.
\n \n\n\n \n 12 March 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nWoodford Investment Management leads round into OxSyBio, the second Oxford University spinout from Oxford Nanopore founder Hagan Bayley
\n \n\n\n \n 6 March 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nSouth Korean and Chinese investors join round into Oxford University spinout developing cancer vaccines.
\n \n\n\n \n 14 February 2018\n \n
\n\n \n\n \n\n \n \n \n \n Events\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nOn Thursday 19 April, Oxford University will play host to an AIMday focused on Biomedical Imaging, which is at the heart of much of the clinical and biomedical research conducted at the University.
\n \n\n\n \n 12 February 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe innovation arm of Oxford University gains impact at board level with the addition of the former Minister for Public Health and Innovation and the former Chief Executive of Oxford Instruments.
\n \n\n\n \n 7 February 2018\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nHealth Data Research UK is awarding \u00a330 million funding to six sites across the UK, including the University of Oxford, to address challenging healthcare issues through use of data science.
\n \n\n\n \n 5 February 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe National Institute of Health Research (NIHR) awarded \u00a34 million to enable state-of-the-art psychological therapy to be delivered via virtual reality (VR) in the NHS, in a project that brings together a team of NHS trusts, universities, a mental health charity, the Royal College of Art, and a University of Oxford spin-out company.
\n \n\n\n \n 26 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nExperts in Med Tech Regulation and Surgical Technologies join the Medical Sciences Division Industry Experts in Residence Scheme.
\n \n\n\n \n 15 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nVaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured \u00a320 million in Series A financing.
\n \n\n\n \n 10 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford, Oxford University Hospitals NHS Foundation Trust and the Patient experience healthcare company Oneview Healthcare have signed a research and development (R&D) agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot.
\n \n\n\n \n 3 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe results of the University's Innovation Photography competition have been announced, with two winners from the Medical Sciences Division.
\n \n\n\n \n 12 December 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe \u00a313m drug discovery partnership between Oxford University, Oxford Sciences Innovation and Evotec supported 12 new projects in first year of operation.
\n \n\n\n \n 7 December 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA new paper published today by the Oxford Martin School calls for \u2018open science\u2019 approaches to drug discovery and offers ways forward that would transform how the medical challenges of this century could be addressed more efficiently.
\n \n\n\n \n 5 December 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nSociologist Alex Rushforth (Nuffield Department of Primary Care Health Sciences), recently attended Oxford\u2019s annual digital health pitching event, The Hill, for the first time. Here\u2019s what he made of it.
\n \n\n\n \n 29 November 2017\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nFinal beam laid for new BioEscalator/Novo Nordisk Building, due to open Summer 2018
\n \n\n\n \n 28 November 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nAugmented and virtual reality spinout 6Degrees revealed as 150th spinout firm from Oxford University.
\n \n\n\n \n 16 November 2017\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe 2017 Oxford University iGEM team have just returned from the competition in Boston with not only a Gold medal but also the extremely competitive award for Best Diagnostics Project in the Undergraduate category. In addition they were nominated for five further awards for best presentation, wiki, model, integrated human practices and best applied design.
\n \n\n\n \n 26 October 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nModified silk from Asian wild silkworms could be used in a strategy to repair damaged spinal cords, according to scientists from the universities of Aberdeen and Oxford.
\n \n\n\n \n 19 October 2017\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA new approach to targeting key cancer-linked proteins, thought to be \u2018undruggable\u2019, has been discovered through an alliance between industry and academia.
\n \n\n